Clinical Trial Update: Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm [Phase 3]

View source ↗

Summary

A Phase 3 confirmatory trial evaluating the safety and efficacy of Hugeltox injectable botulinum toxin type A for essential blepharospasm has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Blepharospasm

Drugs mentioned

• Hugeltox Inj. (botulinum toxin type A)

Snippet

Sponsor: Hugel | Conditions: Essential Blepharospasm | Phase 3 | Status: COMPLETED